Fonds-Crashtest
Fonds | Punkte Gesamt |
Pkt. Perfor- mance |
Pkt. Stress- test |
Pkt. Rating | Perf. 3 Jahre |
Max. Verlust 3 Jahre |
Vol. in Mio. € |
|
---|---|---|---|---|---|---|---|---|
1 | SEB Concept Biotechnology | 221 | 67 | 94 | 60 | 216,7% | 16,8% | 485 |
2 | Candriam Equities Biotechnology | 204 | 53 | 91 | 60 | 233,0% | 20,9% | 667 |
3 | Franklin Biotechnology Discovery Fund | 201 | 80 | 79 | 42 | 226,1% | 23,1% | 2549 |
4 | Julius Baer Health Innovation Fund | 198 | 51 | 97 | 50 | 224,1% | 13,1% | 133 |
5 | Espa Stock Biotec | 170 | 65 | 80 | 25 | 209,7% | 22,5% | 214 |
6 | DWS Biotech | 167 | 71 | 66 | 30 | 229,5% | 24,1% | 522 |
7 | Bellevue Funds BB Biotech | 167 | 66 | 76 | 25 | 240,2% | 22,1% | 59 |
8 | Credit Suisse Biotechnology Equity Fund | 166 | 67 | 74 | 25 | 233,4% | 23,7% | 209 |
9 | Deka-Lux-Biotech CF | 164 | 49 | 85 | 30 | 217,4% | 21,7% | 305 |
10 | UBS Equity Fund Biotech | 161 | 74 | 65 | 22 | 246,9% | 23,8% | 1521 |
11 | FCP OP Medical Bio-Health-Trends | 153 | 34 | 100 | 19 | 143,6% | 12,4% | 119 |
12 | Pictet Biotech | 116 | 26 | 83 | 7 | 185,9% | 23,2% | 1602 |
13 | Allianz Biotechnologie | 116 | 33 | 76 | 7 | 161,2% | 22,1% | 370 |
Punkte Outperformance | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fonds | Punkte Perf. |
Perf. 1 Jahr |
Pkt. Perf. 1 Jahr |
Perf. 3 Jahr |
Pkt. Perf. 3 Jahr |
Perf. 5 Jahr |
Pkt. Perf. 5 Jahr |
ges. | 1. Jahr |
2. Jahr |
3. Jahr |
4. Jahr |
5. Jahr |
|
1 | Franklin Biotechnology Discovery Fund | 80 | 87,5% | 30 | 226,1% | 20 | 346,7% | 20 | 10 | 5 | 0 | -5 | 5 | 5 |
2 | UBS Equity Fund Biotech | 74 | 82,6% | 25 | 246,9% | 25 | 308,8% | 14 | 10 | 5 | 0 | 5 | -5 | 5 |
3 | DWS Biotech | 71 | 86,5% | 27 | 229,5% | 21 | 330,3% | 18 | 5 | 5 | 0 | 0 | 5 | -5 |
4 | SEB Concept Biotechnology | 67 | 74,9% | 21 | 216,7% | 17 | 332,0% | 19 | 10 | 0 | 5 | -5 | 5 | 5 |
5 | Credit Suisse Biotechnology Equity Fund | 67 | 80,4% | 24 | 233,4% | 23 | 315,8% | 15 | 5 | 0 | 0 | 5 | -5 | 5 |
6 | Bellevue Funds BB Biotech | 66 | 84,8% | 26 | 240,2% | 24 | 282,7% | 11 | 5 | 5 | 5 | 5 | -5 | -5 |
7 | Espa Stock Biotec | 65 | 86,6% | 28 | 209,7% | 16 | 320,9% | 16 | 5 | 5 | -5 | -5 | 5 | 5 |
8 | Candriam Equities Biotechnology | 53 | 78,6% | 23 | 233,0% | 22 | 298,5% | 13 | -5 | 0 | 0 | 5 | -5 | -5 |
9 | Julius Baer Health Innovation Fund | 51 | 72,6% | 20 | 224,1% | 19 | 322,6% | 17 | -5 | -5 | 5 | -5 | 5 | -5 |
10 | Deka-Lux-Biotech CF | 49 | 86,8% | 29 | 217,4% | 18 | 291,7% | 12 | -10 | 5 | -5 | -5 | 0 | -5 |
11 | FCP OP Medical Bio-Health-Trends | 34 | 40,1% | 18 | 143,6% | 13 | 183,1% | 8 | -5 | -5 | 5 | -5 | -5 | 5 |
12 | Allianz Biotechnologie | 33 | 67,9% | 19 | 161,2% | 14 | 224,5% | 10 | -10 | -5 | -5 | 0 | 5 | -5 |
13 | Pictet Biotech | 26 | 77,5% | 22 | 185,9% | 15 | 209,6% | 9 | -20 | 0 | -5 | -5 | -5 | -5 |
Fonds | Pkt Stresstest |
Vola 3 Jahre | Pkt. Vola 3 Jahre |
Max. Draw-down 3 Jahre |
Pkt. Max. Drawdown 3 Jahre |
Beta Faktor 3 Jahre |
Pkt. Beta Faktor 3 Jahre |
|
---|---|---|---|---|---|---|---|---|
1 | FCP OP Medical Bio-Health-Trends | 100 | 14,2% | 30 | 12,4% | 40 | 0,65 | 30 |
2 | Julius Baer Health Innovation Fund | 97 | 16,7% | 29 | 13,1% | 39 | 0,85 | 29 |
3 | SEB Concept Biotechnology | 94 | 16,9% | 28 | 16,8% | 38 | 0,86 | 28 |
4 | Candriam Equities Biotechnology | 91 | 19,1% | 27 | 20,9% | 37 | 1,00 | 27 |
5 | Deka-Lux-Biotech CF | 85 | 19,8% | 25 | 21,7% | 36 | 1,05 | 24 |
6 | Pictet Biotech | 83 | 19,6% | 26 | 23,2% | 31 | 1,03 | 26 |
7 | Espa Stock Biotec | 80 | 19,8% | 24 | 22,5% | 33 | 1,06 | 23 |
8 | Franklin Biotechnology Discovery Fund | 79 | 20,2% | 22 | 23,1% | 32 | 1,04 | 25 |
9 | Allianz Biotechnologie | 76 | 21,0% | 20 | 22,1% | 34 | 1,08 | 22 |
10 | Bellevue Funds BB Biotech | 76 | 20,7% | 21 | 22,1% | 35 | 1,11 | 20 |
11 | Credit Suisse Biotechnology Equity Fund | 74 | 20,2% | 23 | 23,7% | 30 | 1,08 | 21 |
12 | DWS Biotech | 66 | 21,3% | 19 | 24,1% | 28 | 1,13 | 19 |
13 | UBS Equity Fund Biotech | 65 | 22,4% | 18 | 23,8% | 29 | 1,19 | 18 |
Fonds | Pkt Ratings |
Feri | Pkt. Feri |
FWW Fundstars |
Pkt. FWW Fundstars |
Lipper | Pkt. Lipper |
Morningstar | Pkt. Morningstar |
Sauren | Pkt. Sauren |
Telos | Pkt. Telos |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | SEB Concept Biotechnology | 60 | B | 10 | 5 | 20 | 15 | 10 | 4 | 10 | 0 | 5 | 10 | |
2 | Candriam Equities Biotechnology | 60 | B | 10 | 5 | 20 | 17 | 10 | 4 | 10 | 0 | 5 | 10 | |
3 | Julius Baer Health Innovation Fund | 50 | B | 10 | 5 | 20 | 15 | 10 | 0 | 0 | 5 | 10 | ||
4 | Franklin Biotechnology Discovery Fund | 42 | B | 10 | 3 | 5 | 17 | 10 | 4 | 10 | 0 | 4 | 7 | |
5 | DWS Biotech | 30 | B | 10 | 1 | 0 | 12 | 5 | 3 | 5 | 0 | 5 | 10 | |
6 | Deka-Lux-Biotech CF | 30 | C | 5 | 3 | 5 | 12 | 5 | 3 | 5 | 0 | 5 | 10 | |
7 | Bellevue Funds BB Biotech | 25 | C | 5 | 4 | 10 | 11 | 5 | 3 | 5 | 0 | 0 | ||
8 | Espa Stock Biotec | 25 | B | 10 | 3 | 5 | 12 | 5 | 3 | 5 | 0 | 0 | ||
9 | Credit Suisse Biotechnology Equity Fund | 25 | C | 5 | 4 | 10 | 11 | 5 | 3 | 5 | 0 | 0 | ||
10 | UBS Equity Fund Biotech | 22 | C | 5 | 2 | 0 | 12 | 5 | 3 | 5 | 0 | 4 | 7 | |
11 | FCP OP Medical Bio-Health-Trends | 19 | D | 0 | 2 | 0 | 13 | 5 | 2 | 0 | 3 | 10 | 3 | 4 |
12 | Allianz Biotechnologie | 7 | D | 0 | 1 | 0 | 7 | 0 | 2 | 0 | 0 | 4 | 7 | |
13 | Pictet Biotech | 7 | E | 0 | 1 | 0 | 9 | 0 | 2 | 0 | 0 | 4 | 7 |
Sortierkriterium: Punkte Gesamt, Quelle: Testverfahren DER FONDS, Berechnung und Daten: FWW Fundservices GmbH (Stichtag: 8. April 2015), Wertentwicklung auf Euro-Basis